These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1461 related articles for article (PubMed ID: 32231001)

  • 21. Extracellular vesicles in liver disease and potential as biomarkers and therapeutic targets.
    Szabo G; Momen-Heravi F
    Nat Rev Gastroenterol Hepatol; 2017 Aug; 14(8):455-466. PubMed ID: 28634412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extracellular vesicles: Novel mediator for cell to cell communications in liver pathogenesis.
    Devhare PB; Ray RB
    Mol Aspects Med; 2018 Apr; 60():115-122. PubMed ID: 29122679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liquid Biopsy for the Diagnosis of Viral Hepatitis, Fatty Liver Steatosis, and Alcoholic Liver Diseases.
    Shabangu CS; Huang JF; Hsiao HH; Yu ML; Chuang WL; Wang SC
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32466319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emerging role of extracellular vesicles in liver diseases.
    Malhi H
    Am J Physiol Gastrointest Liver Physiol; 2019 Nov; 317(5):G739-G749. PubMed ID: 31545919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipid-Induced Signaling Causes Release of Inflammatory Extracellular Vesicles From Hepatocytes.
    Hirsova P; Ibrahim SH; Krishnan A; Verma VK; Bronk SF; Werneburg NW; Charlton MR; Shah VH; Malhi H; Gores GJ
    Gastroenterology; 2016 Apr; 150(4):956-67. PubMed ID: 26764184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Emerging Role of Extracellular Vesicles and Autophagy Machinery in NASH-Future Horizons in NASH Management.
    Trifylli EM; Kriebardis AG; Koustas E; Papadopoulos N; Deutsch M; Aloizos G; Fortis SP; Papageorgiou EG; Tsagarakis A; Manolakopoulos S
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extracellular Vesicles in Non-alcoholic Fatty Liver Disease and Alcoholic Liver Disease.
    Wu D; Zhu H; Wang H
    Front Physiol; 2021; 12():707429. PubMed ID: 34335310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extracellular vesicles in liver diseases.
    Maji S; Matsuda A; Yan IK; Parasramka M; Patel T
    Am J Physiol Gastrointest Liver Physiol; 2017 Mar; 312(3):G194-G200. PubMed ID: 28039157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extracellular Vesicles in the Development of the Non-Alcoholic Fatty Liver Disease: An Update.
    Dorairaj V; Sulaiman SA; Abu N; Abdul Murad NA
    Biomolecules; 2020 Oct; 10(11):. PubMed ID: 33143043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human milk-derived extracellular vesicles alleviate high fat diet-induced non-alcoholic fatty liver disease in mice.
    Jiang X; Wu Y; Zhong H; Zhang X; Sun X; Liu L; Cui X; Chi X; Ji C
    Mol Biol Rep; 2023 Mar; 50(3):2257-2268. PubMed ID: 36575319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extracellular Vesicles and Their Correlation with Inflammatory Factors in an Experimental Model of Steatotic Liver Disease Associated with Metabolic Dysfunction.
    Keingeski MB; Longo L; Brum da Silva Nunes V; Figueiró F; Dallemole DR; Pohlmann AR; Vier Schmitz TM; da Costa Lopez PL; Álvares-da-Silva MR; Uribe-Cruz C
    Metab Syndr Relat Disord; 2024 Jun; 22(5):394-401. PubMed ID: 38498801
    [No Abstract]   [Full Text] [Related]  

  • 32. Extracellular Vesicles as Inflammatory Drivers in NAFLD.
    Srinivas AN; Suresh D; Santhekadur PK; Suvarna D; Kumar DP
    Front Immunol; 2020; 11():627424. PubMed ID: 33603757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extracellular Vesicles in Cardiovascular Theranostics.
    Bei Y; Das S; Rodosthenous RS; Holvoet P; Vanhaverbeke M; Monteiro MC; Monteiro VVS; Radosinska J; Bartekova M; Jansen F; Li Q; Rajasingh J; Xiao J
    Theranostics; 2017; 7(17):4168-4182. PubMed ID: 29158817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extracellular vesicles and their nucleic acids for biomarker discovery.
    Momen-Heravi F; Getting SJ; Moschos SA
    Pharmacol Ther; 2018 Dec; 192():170-187. PubMed ID: 30081050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exosomes: Nomenclature, Isolation, and Biological Roles in Liver Diseases.
    Park SH; Lee EK; Yim J; Lee MH; Lee E; Lee YS; Seo W
    Biomol Ther (Seoul); 2023 May; 31(3):253-263. PubMed ID: 37095734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of microRNAs in alcohol-induced liver disorders and non-alcoholic fatty liver disease.
    Torres JL; Novo-Veleiro I; Manzanedo L; Alvela-Suárez L; Macías R; Laso FJ; Marcos M
    World J Gastroenterol; 2018 Sep; 24(36):4104-4118. PubMed ID: 30271077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of the immune system in the pathogenesis of NAFLD and potential therapeutic impacts of mesenchymal stem cell-derived extracellular vesicles.
    Moayedfard Z; Sani F; Alizadeh A; Bagheri Lankarani K; Zarei M; Azarpira N
    Stem Cell Res Ther; 2022 Jun; 13(1):242. PubMed ID: 35672797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Communication between nonalcoholic fatty liver disease and atherosclerosis: Focusing on exosomes.
    Zhao X; Kong X; Cui Z; Zhang Z; Wang M; Liu G; Gao H; Zhang J; Qin W
    Eur J Pharm Sci; 2024 Feb; 193():106690. PubMed ID: 38181871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intercellular Communication between Hepatic Cells in Liver Diseases.
    Sato K; Kennedy L; Liangpunsakul S; Kusumanchi P; Yang Z; Meng F; Glaser S; Francis H; Alpini G
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31052525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating Extracellular Vesicles As Biomarkers and Drug Delivery Vehicles in Cardiovascular Diseases.
    de Freitas RCC; Hirata RDC; Hirata MH; Aikawa E
    Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33808038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 74.